King's College London
Joined November 2019
🎉Celebrations are in full swing for our #COVID19 Emerging Leaders Prize winners! 🏆Dr Katie Doores @DooresLab 🏆Dr Rosalind Eggo @rozeggo 🏆Dr Antonia Ho @DrToniHo 🏆Dr Koen Pouwels @kb_pouwels Huge thanks to our sponsor @Pfizer_UK and speakers @BPhillipsPfizer & @Daltmann10👏
4
9
5
55
OUT NOW: Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern #SARSCoV2 By Katie Doores & co @DooresLab read it here: rdcu.be/czzqM nature.com/articles/s41564-0…
5
3
PhD opportunity starting Sept 2021! Sensitising solid cancers to CAR T-cell therapy using matrix remodelling bacteria. You'll be working between @QMBCI and an exciting new biotech start-up. findaphd.com/phds/project/se…
29
24
#SARSCoV2_Spike #B117_variant | Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes | Katie Doores @KingsCollegeLon @ImmunityCP buff.ly/3rQBNgw
DooresLab retweeted
Dr Katie Doores. “Development of a safe and effective HIV vaccine will have a huge impact on global health.” Dr Doores research encompasses the development of carbohydrate-based vaccines and therapeutics, and neutralising antibody responses against pathogenic viruses.
1
1
1
3